Skye Bioscience Inc (SKYE)
5.53
+0.21
(+3.95%)
USD |
NASDAQ |
Nov 14, 16:00
5.53
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Shareholders Equity (Quarterly): 75.80M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 75.80M |
June 30, 2024 | 72.81M |
March 31, 2024 | 78.88M |
December 31, 2023 | -2.132M |
September 30, 2023 | 1.695M |
June 30, 2023 | -7.789M |
March 31, 2023 | -4.781M |
December 31, 2022 | -3.008M |
September 30, 2022 | -3.285M |
June 30, 2022 | -0.3018M |
March 31, 2022 | 2.973M |
December 31, 2021 | 5.864M |
September 30, 2021 | 8.265M |
June 30, 2021 | 2.271M |
March 31, 2021 | 2.479M |
December 31, 2020 | 0.4508M |
September 30, 2020 | 1.853M |
June 30, 2020 | -3.094M |
March 31, 2020 | -1.703M |
December 31, 2019 | 0.5481M |
September 30, 2019 | -16.40M |
June 30, 2019 | -11.64M |
March 31, 2019 | -27.86M |
December 31, 2018 | -15.56M |
Date | Value |
---|---|
September 30, 2018 | -10.16M |
June 30, 2018 | -8.245M |
March 31, 2018 | -5.754M |
December 31, 2017 | -0.8001M |
September 30, 2017 | -2.105M |
June 30, 2017 | -1.778M |
March 31, 2017 | -1.229M |
December 31, 2016 | -1.451M |
September 30, 2016 | -1.019M |
June 30, 2016 | -0.2555M |
March 31, 2016 | -1.010M |
December 31, 2015 | 0.471M |
September 30, 2015 | 1.026M |
June 30, 2015 | -0.861M |
March 31, 2015 | -0.3384M |
December 31, 2014 | -0.4535M |
September 30, 2014 | 0.7763M |
July 31, 2014 | 0.0811M |
April 30, 2014 | 0.0734M |
January 31, 2014 | 0.087M |
October 31, 2013 | 0.0834M |
July 31, 2013 | 0.0647M |
April 30, 2013 | 0.0656M |
October 31, 2012 | 0.0386M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-7.789M
Minimum
Jun 2023
78.88M
Maximum
Mar 2024
11.39M
Average
1.122M
Median
Shareholders Equity (Quarterly) Benchmarks
Oramed Pharmaceuticals Inc | 177.06M |
Viking Therapeutics Inc | 911.45M |
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 81.54M |
Total Liabilities (Quarterly) | 5.732M |